ArticleOncotarget2018

Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy.

Christina A von Roemeling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.